Dr. Taha Completes IGCS Curriculum

Congratulations to Dr. Mohammed Taha Hussein Alsayed from the Women's Wellness and Research Center in Qatar for successfully completing the IGCS Gynecologic Oncology Global Curriculum & Mentorship Program!

Dr. Mohammed Taha Hussein Alsayed
Women’s Wellness and Research Centre, Hamad Medical Corporation, Doha, Qatar
 
“Thanks to IGCS for supporting the IGCS fellowship program in Qatar. This kind of training was impossible in our hospital two years ago, and now that I have completed the fellowship program, I will be able to deliver better service to women with gynecological malignancies. Thanks to Dr. Vivek, Dr. Herod and Dr. Afaf for their support the last two years, and thanks to IGCS team member, Susan Ralph, for all her hard work that made everything run easy and smooth.”

The IGCS Global Curriculum was established in 2017 under the leadership of then-President, Michael Quinn. It is a comprehensive two-year education and training program designed for regions around the world that do not currently have formal training in gynecologic oncology. Click here to learn more about the program.

Congratulations to Dr. Taha on achieving this important milestone. Many thanks to the local and international mentors for their support and guidance.

Local Mentors & Faculty

Women’s Wellness and Research Centre, Hamad Medical Corporation
Doha, Qatar

Dr. Jonathan Herod

Local Mentor

Dr. Afaf Al-Ansari

Local Mentor

Dr. Hilal Al-Rifai

Medical Director

Dr. Moayyad

Chair of Gynecology

International Mentors

Dr. Vivek Arora

Australia

Dr. Herod, Local Mentor, congratulates Dr. Taha:
"There have been few achievements in my long and varied career that have given me greater pleasure than seeing our first Gynecologic Oncology Fellow in Qatar complete his training in the IGCS Global Curriculum. Dr Taha has been an excellent Fellow and his commitment to his training has been exceptional. It is certain that all of our team have also benefitted greatly from our involvement with the training program and we would not have been able to progress as a team in the manner we have over the past few years without the support of the IGCS."
Volunteer to Support IGCS Mentorship & Training Programs
We are always looking for volunteer leaders of all disciplines to support our mentorship and training programs. If you are interested in becoming a mentor or contributing to our virtual tumor boards, please contact Susan Ralph at susan.ralph@igcs.org.

Patient Perspectives Roundtable

Focus on Survivorship/Quality of Life and Patient-Reported Outcomes
Friday, August 6, 2021
9:00 am CDT | 2:00 pm UTC

This 90-minute Virtual Patient Perspectives Roundtable, “Focus on Survivorship/Quality of Life and Patient-Reported Outcomes," is the third in a series of four roundtables sponsored by GSK.

These topics are relevant to patient overall survival, well-being/quality of life, care, and outcomes and cover patient assessments of their cancer experience, all in and beyond the backdrop of COVID-19 and of global discussions of health equity. Participating in this active exchange of information will enhance understanding of these important topics and empower attendees.

Moderator
Rosalind Glasspool, MD
IGCS Council Member
Medical Oncologist, National Health Service Greater Glasgow and Clyde
Scotland
 
Panelists
Raimundo Correa, MD
Gynecologic Oncologist
Palliative Care Sub-Specialist
Staff Physician, Hospital Santiago Oriente & Clinica Las Condes
Chile
 
Sally Kwenda
Patient Advocate
HIV/AIDS Counselor
Member, Noncommunicable Disease Alliance-Kenya
Global Hero of Hope
Kenya
 
Sharon Manne, PhD
Clinical Psychologist
Professor of Medicine
Chief of Behavioral Science
Founder & Co-Director of Center of Excellence in Cancer Survivorship
Rutgers Cancer Institute of New Jersey
USA
 
Eva-Maria Strömsholm, RN
Patient Advocate
Nurse/Teacher
Co-Founder & Vice-Chair, Gynecological Cancerpatients Finland
Member, Board of Cancer Society of Finland
Finland
Save the Date:
Global Health Equity: Conversation to Implementation
Friday, October 15, 2021
9:00 am CDT | 2:00 pm UTC

About the IGCS Patient Perspectives Roundtable Series
During the COVID-19 pandemic and in its aftermath, IGCS will continue to be a global source of education and resources, training, public awareness, and advocacy. Virtual Roundtables will

  • facilitate first-hand assessment of patient community needs and concerns
  • provide vetted information, assessments, and guidance from key opinion leaders and seasoned survivors/advocates
  • address current patient and wider community concerns through live responses to question posted online during the session
  • promote strategic conversations with health care and research communities around specific issues
  • assist all in coming to workable solutions and strategies for moving forward during the COVID-19 pandemic and in its aftermath

Each 60- to 90-minute session will cover a specific topic important to the gynecologic cancer patient communities maneuvering through the health and cancer care system during and after COVID-19 and will include IGCS key opinion leaders, patients-caregivers, and other stakeholders appropriate to the topic.

Previous Roundtables

Spotlight on Endometrial Cancer: Breakthroughs & Concerns
Recorded on May 14, 2021
Sponsored by GSK

Navigating Telehealth/Telemedicine & Embracing Shared Decision Making
Recorded November 21, 2020
Sponsored by GSK

Patient Advocacy & Support in the Backdrop of COVID-19
Recorded June 30, 2020

Gynecologic Cancer Patient Care & Clinical Trials in the Midst of COVID-19
Recorded May 23, 2020
Sponsored by GOG Foundation

2021 IGCS Business Meeting

Dear IGCS Members:

In accordance with Article III Section 3 of the International Gynecologic Cancer Society bylaws, we hereby notify all members of the upcoming Business Meeting of the Society.

The 2021 Business Meeting of the International Gynecologic Cancer Society will be held during the IGCS Annual Global Meeting on Tuesday, August 31 from 11:30 am – 12:00 pm CET in the Sinopoli Room at the Auditorium Parco della Musica in Rome, Italy.

IGCS Members joining us in Rome are encouraged to attend and it will be broadcast to our virtual audience simultaneously. Annual Global Meeting registration is required.

Topics discussed will include committee reports, the 2020 audited financial report, current membership data, an update from the International Journal of Gynecological Cancer, and new business. Click here to view the agenda.

If you would like to bring up new business, please contact me at mary.eiken@igcs.org prior to the meeting.

Sincerely,

Mary Eiken
IGCS CEO

Introducing IGCS COVID Safety Officer

Introducing IGCS COVID Safety Officer, Dr. Alessandro Cartelli

COVID-19 Health & Safety Guidelines and Requirements

  • Rapid testing is required for all delegates. Testing will be offered at the meeting venue on Sunday, August 29 and will remain available throughout the conference.
  • All meeting delegates must be tested by the IGCS COVID team and show a negative test result at the time of registration in order to enter the venue.

COVID-19 Health & Safety Guidelines and Requirements

  • Rapid testing is required for all delegates. Testing will be offered at the meeting venue on Sunday, August 29 and will remain available throughout the conference.
  • All meeting delegates must be tested by the IGCS COVID team and show a negative test result at the time of registration in order to enter the venue.
  • Face masks must be worn by all delegates at the congress while indoors as an extra safety precaution.
  • To accommodate social distancing at the Auditorium, a maximum of 500 in-person tickets will be sold. Seating within the halls has been spaced to adhere to social distance guidelines, currently 1m.
  • If a delegate tests positive for COVID-19, a molecular PCR test will be issued. If found positive, the delegate will not be allowed to enter the auditorium and will be advised on safe transportation from the auditorium to their hotel.

COVID-19 Health & Safety FAQ

Q: What Coronavirus-related safety precautions are being taken for meeting delegates in Rome?
A: IGCS is committed to the health and safety of our delegates, staff, and everyone who works at the meeting venue. We have been working closely with officials at the Auditorium, the local conference organizer, and receiving updates from the Italian government and we have implemented the following guidelines and procedures regarding COVID-19 safety.

Q: How many people will be able to attend in-person?
A: To accommodate social distancing at the Auditorium, a maximum of 500 in-person tickets will be sold.

Q: What is the COVID Safety Officer’s responsibility?
A: IGCS has appointed Dr. Alessandro Cartelli as COVID Safety Officer. He will be responsible for ensuring that guidelines are followed, and proper steps are taken in the event of a positive COVID case. For questions, please email Dr. Cartelli.

Q: What testing will be required to be admitted to the meeting venue?
A: Our onsite team will be conducting rapid testing with the STANDARD Q COVID-19 Ag Test by SD BIOSENSOR.  It is a rapid chromatographic immunoassay for the qualitative detection of specific antigens to SARS-CoV-2 present in human nasopharynx, approved by the Italian and European FDA and is valid for the screening of this population. The specimen is collected though a nasopharyngeal swab. Test results will be available after 15 minutes and those who test negative will proceed to registration to collect their Congress information.

Q: When will I need to be tested?
A: All meeting delegates must be tested by the IGCS COVID team and show a negative test at the time of registration. Testing will be offered at the meeting venue on Sunday, August 29, 2021 and will remain available throughout the conference.

Q: Is IGCS testing required if I recently completed testing somewhere else?
A: Yes, the test done by IGCS is required. COVID tests that have been done elsewhere and Green passes issued in the EU will not be accepted to grant access to the Congress. All delegates must have a negative test performed by the IGCS team at the venue. IGCS is covering the cost of the required COVID test for entry.

Q: What if I am not in Rome on August 29th to get tested by the IGCS team?
A: Testing stations will be available throughout the duration of the meeting.

Q: What happens if I test positive for COVID-19?
A: If a delegate tests positive for COVID-19, a molecular PCR test will be issued. If found positive, the delegate will not be allowed to enter the auditorium and will be advised on safe transportation from the auditorium to their hotel. The IGCS COVID team will provide them with information and assistance on local medical care and further testing facilities as needed. Note that any required PCR testing and transportation away from the venue will be at the expense of the delegate. The delegate will receive a registration conversion from an in-person pass to a virtual pass and will receive the appropriate refund in price in adherence to the IGCS registration conversion and cancellation policy.

Q: What are the current safety measures in place at The Auditorium?
A: The Auditorium has provided detailed safety measures that will be shared with delegates attending in-person in advance of the meeting. At this time, guidelines include but are not limited to:

  • Temperature checks upon entering the Auditorium.
  • All those entering the Auditorium will be required to wear an FFP2 face mask at all times while in the Auditorium.   
  • Seating within the halls has been spaced to adhere to social distance guidelines, currently 1m. A maximum of 500 delegates will be allowed.
  • Notices stating safety regulations to be followed, aimed principally at the audience, will be displayed at various points inside the Auditorium.

Q: Is there any information that I need to be aware of regarding COVID-19 and travel?
A: Click here for important information from the Italian Ministry of Health regarding travel and COVID-19. This includes specific information about the classification of territories, travel restrictions, rules, and requirements for travelling to and from abroad.

Dr. Chege Completes IGCS Curriculum

Congratulations to Dr. Henry Chege from Moi University in Kenya for completing the IGCS Gynecologic Oncology Global Curriculum & Mentorship Program!

Dr. Henry Chege
Moi University, Kenya

“I thank all of you for the support you accorded me during the IGCS fellowship training. To the international mentors Prof. Barry and Prof. Al Covens, thank you for taking time to travel all the way to Kenya to supervise the training. I will always be indebted to these great mentors.”

This fellowship program is the first fellowship in any medical field approved by Moi University. The IGCS Global Curriculum was established in 2017 under the leadership of then-President, Michael Quinn. It is a comprehensive two-year education and training program designed for regions around the world that do not currently have formal training in gynecologic oncology. Click here to learn more about the program.

Congratulations to Dr. Chege on achieving this important milestone. Many thanks to the local and international mentors for their support and guidance.

Local Mentors

Dr. Benjamin Elly
Moi University
Kenya

Dr. Peter Itsura
Moi University
Kenya

Dr. Omenge Orango
Moi University
Kenya

International Mentors

Dr. Barry Rosen
Beaumont Gynecologic Oncology
USA

Dr. Al Covens
Sunnybrook Health Sciences Centre
The University of Toronto
Canada

Dr. Barry Rosen, International Mentor congratulates Dr. Chege: "You made a very impressive, total commitment Henry, giving up your clinic practice, giving up money you would have made to do this training. And you had delays (out of your control) along the way which must have been very frustrating. It is a very big accomplishment. You are now internationally recognized for your expertise. Kenyan women will benefit so much from your expertise and your future training of other doctors. I wish I could be in Kenya to congratulate you in person.”

Volunteer to Support IGCS Mentorship & Training Programs

We are always looking for volunteer leaders of all disciplines to support our mentorship and training programs. If you are interested in becoming a mentor or contributing to our virtual tumor boards, please contact Susan Ralph at susan.ralph@igcs.org.

IGCS 2021 Registration Options

In this video message, Scientific Program Committee Co-Chair, Dr. Matthew Powell, describes the multiple ways you can register for IGCS 2021.

Whether you choose to attend the Annual Meeting in Rome, virtually, or by gathering locally, IGCS 2021 is a great opportunity to expand your professional network and collaborate with colleagues from around the world.

Register for IGCS 2021

Group Registration 

 

Did you miss our last video message?
View Dr. Coleman’s video message regarding the Presidential Plenary at IGCS 2021.

IGCS 2021 Presidential Plenary

In this video message, Dr. Coleman reveals that this year’s Presidential Plenary will focus on current clinical trials and international efforts to work cooperatively, ensuring research dedicated to women’s cancers continues to advance globally.

The Presidential Plenary will be held on Tuesday, August 31 at 2:10pm Central European Time.

During the plenary, invited guests from the GOG – (Gynecologic Oncology Group Partners) and ENGOT – (the European Network for Gynaecological Oncological Trial Group) will share the latest information and relevant clinical trials in progress. These groups operate through global partnerships and emulate so much of how the IGCS operates day in and day out… through the success of partnerships and international collaboration.

 

Breast Cancer Course

International Course on Breast Cancer
Three-Part Webinar Series

Associate Professor: Dr. Víctor Manuel Vargas Hernández

Adjunct Professors:
Dr. Guillermo Sídney Herbert Núñez
Dr. David Cantú de León

Coordinators:
Dr. Antonio Posada Domínguez
Dr. Paula Anel Cabrera
Dr. José Hinojosa Gómez

Descargar el Programa (Español)

 

Parte 1: Diagnósticos
Grabado el 27 de Marzo de 2021


Parte 2: Tratamiento Quirúrgico y Quimioterápico
Grabado el 24 de Abril de 2021


Parte 3: Tratamiento de Radioterapia
Grabado el 29 de Mayo de 2021

Conversations with Coleman

Watch the most recent episode of Conversations with Coleman, a conversation with the IGCS 2021 Annual Global Meeting Scientific Program Committee Chairs

Watch the latest episode of Conversations with Coleman where Dr. Coleman is joined by the 2021 Scientific Program Committee Chairs, Dr. Ana Oaknin (Spain) and Dr. Matthew Powell (USA). They discussed the 2021 IGCS Annual Global Meeting to be held in Rome this August 30 -September 2. Watch and learn about their bold plans to host an in-person meeting with a virtual component using a hub and spoke concept, abstract submission information, and key pieces of the program.

Previous Episodes

Conversations with Coleman, Celebrating World Cancer Day!

In this special episode of Conversations with Coleman, IGCS President, Dr. Robert Coleman is joined by IGCS CEO, Mary Eiken to discuss World Cancer Day

They discuss the themes and key issues surrounding World Cancer Day, IGCS’s advocacy initiatives, and the importance of the IGCS Health Equity Statement as a guidepost to programing. They also talk about IGCS’s membership with the Union for International Cancer Control (UICC) and answer questions from the viewers.

This was episode was recorded live on February 1st: Many thanks to those who joined us live (85 participants from 34 countries) and submitted questions!

In this episode, Dr. Coleman is joined by IGCS past Presidents, Dr. Michael Quinn and Dr. Roberto Angioli, and future President Dr. Keiichi Fujiwara. They discuss how they each first became involved with the IGCS, key member benefits, and the origin of the Strategic Alliance Partner Program. They also talk about the diversity of the IGCS Council, the importance of volunteer leaders in achieving strategic goals for the society, and give advice to members who are interested in becoming more involved with IGCS initiatives and programs.

In this first video message, Dr. Coleman discusses the goals of this web series, explains why he decided to become involved with the International Gynecologic Cancer Society over 25 years ago, and why he thinks the society is unique and important. He also touches on his leadership style and how he plans to engage the IGCS Council Members during his term as IGCS President.

 

Garima Yadav Member Spotlight

IGCS offers members the opportunity to share their stories with the greater gynecologic oncology community, inspire care givers around the world and strengthen awareness of the profession and society. IGCS Member Spotlights highlight the achievements, contributions, and personal stories of members within the worldwide women’s cancer care community.

Meet Garima Yadav, an IGCS Member and Associate Professor at the All India Institute of Medical Sciences in Jodhpur, India.

Where did you complete your training? Or tell us about your background in gyn oncology.
I completed my training at the University College of Medical Sciences in Delhi and Tata Memorial Centre in Mumbai, India. Since 2018, I have been working in the field of gynecologic oncology in a tertiary care centre in western Rajasthan.

Why did you decide to pursue a career in gyn oncology or what about it interested you?
During my residency, I had the fortune of working in the busiest referral hospital in the capitol of India and saw women with gynecological cancers from all over the country. The multidisciplinary management, fascinating surgeries and overall caring for these women attracted me to this field.

Tell us about your work in women’s cancer: daily activities and/or special projects.
I am presently working at a tertiary referral centre in western Rajasthan with state of the art patient care. I am regularly conducting awareness classes for our women about breast and gynecological malignancies. Along with this, we are involved in screening women for cervical cancers, all kinds of pre-invasive cancer diagnosis and treatment. We operate on all kinds of early and advanced stage gynecological malignancies 3-4 times a week and conduct a weekly follow up clinic. I am also an active executive member of the Rajasthan state chapter of Association of Gynecologic oncologists of India (AGOI).

Tell us about the person or people who have inspired you the most in your career.
There are many renowned gynecologic oncologists from India and abroad whom I dearly look up to like my teachers Dr. Shalini Rajaram, Dr. Amita Maheshwari and Dr. Pratibha Singh. I was highly inspired by Dr. Pedro T. Ramirez when I heard him discussing LACC trial results at the 2018 IGCS Annual Meeting in Kyoto, Japan…Click here to read more 

You Could be Next in the Spotlight! To be featured in the IGCS Member Spotlight, please complete a brief questionnaire to tell us more about yourself and what its like to practice gynecologic oncology in your part of the world. We would love to hear your story.  Complete the questionnaire and read other member highlights here